SCHEMBL17405260

SCHEMBL17405260

c1ccc(-n2c3ccccc3c3c2c2oc4ccccc4c2c2c4ccccc4n(-c4cccc(-c5ccccn5)n4)c23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ ALPL P05186 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ ALPI P09923 1/20 0.33
▸ ALPG P10696 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CCR1 P32246 1/20 0.33
▸ CCR5 P51681 1/20 0.33
▸ CCR8 P51685 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ PPARG P37231 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NR2E3 Q9Y5X4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17405247 0.90 KDM4E (0.38) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405271 0.89 KDM4E (0.35) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405358 0.88 ALDH1A1 (0.37) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17406084 0.88 ALDH1A1 (0.37) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405313 0.87 SMN1; SMN2 (0.34) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405314 0.87 LMNA (0.34) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL16275352 0.87 KDM4E (0.38) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405300 0.86 ALDH1A1 (0.34) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405311 0.86 ALDH1A1 (0.34) LMNAKDM4ESMN1; SMN2L3MBTL1TP53
SCHEMBL17405277 0.85 ALDH1A1 (0.35) LMNAKDM4ESMN1; SMN2L3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 — — US disclosed
US-9887367-B2 Heterocyclic compound, material for organic electroluminescent elements using same, organic electroluminescent element using same, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2018-02-06 — — US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 — — US disclosed
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160005977-A1 HETEROCYCLIC COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS USING SAME, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE ODC1, NOTUM, OR10J3 LMNA 2015/4885KDM4E 1073/4885SMN1; SMN2 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback